HIGHLIGHTS
- who: Canan G. Nebigil from the Kumamoto University, Japan have published the article: Evidence for reciprocal network interactions between injured hearts and cancer, in the Journal: (JOURNAL)
- what: Anti-Inflammatory Thrombosis Outcome Study (CANTOS) has also confirmed this study showing that canakinumab an IL-1u03b2-targeting antibody has beneficial effects on cardiovascular events . Inhibition of the ActRIIBa in this study has fully restored the loss of muscle during cancer cachexia, without altering the high levels of the inflammatory cytokine levels. One of the important reasons for cardiotoxicity is that the anticancer drugs use similar pathways . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.